BRSYF
BrainsWay Ltd.
Price Chart
Latest Quote
$16.84
+0.00 (+0.00%)
Current Price
| Previous Close | $16.84 |
| Open | $13.54 |
| Day High | $13.55 |
| Day Low | $13.54 |
| Volume | 300 |
Stock Information
| Shares Outstanding | 40.09M |
| Total Debt | $6.71M |
| Cash Equivalents | $58.64M |
| Revenue | $56.22M |
| Net Income | $8.76M |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $675.16M |
| P/E Ratio | 76.55 |
| EPS (TTM) | $0.22 |
| Exchange | PNK |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $590.80M |
| Sales | $56.22M |
| Income | $8.76M |
| Book/sh | $1.99 |
| Cash/sh | $1.46 |
| Employees | 129 |
Financial Ratios
| Quick Ratio | 2.81 |
| Current Ratio | 3.34 |
| Debt/Eq | 8.85 |
| EPS Growth TTM | 106.90% |
Returns & Margins
| ROA | 3.31% |
| ROE | 12.55% |
| Gross Margin | 75.51% |
| Operating Margin | 12.91% |
| Profit Margin | 15.58% |
Ownership
| Insider Ownership | 15.15% |
| Institutional Ownership | 10.49% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 129.54 |
| P/S | 12.01 |
| P/B | 8.48 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $16.84 |
| SMA50 | $14.70 |
| SMA200 | $10.00 |
| RSI | nan |
| Shares Float | 26.59M |
| Volatility | 0.15 |
Performance History
| Week | +0.00% |
| Month | +24.28% |
| Quarter | +41.87% |
| 6 Months | +98.12% |
| YTD | +92.90% |
| Year | +395.29% |
| 3 Years | +1771.11% |
| 5 Years | +305.78% |
| 10 Years | +392.40% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-04 | $16.84 | 0 |
| 2026-06-03 | $16.84 | 0 |
| 2026-06-02 | $16.84 | 0 |
| 2026-06-01 | $16.84 | 0 |
| 2026-05-29 | $16.84 | 0 |
| 2026-05-28 | $16.84 | 0 |
| 2026-05-27 | $16.84 | 0 |
| 2026-05-26 | $16.84 | 0 |
| 2026-05-22 | $16.84 | 0 |
| 2026-05-21 | $16.84 | 0 |
| 2026-05-20 | $16.84 | 0 |
| 2026-05-19 | $16.84 | 0 |
| 2026-05-18 | $16.84 | 0 |
| 2026-05-15 | $16.84 | 0 |
| 2026-05-14 | $16.84 | 0 |
| 2026-05-13 | $16.84 | 0 |
| 2026-05-12 | $16.84 | 0 |
| 2026-05-11 | $16.84 | 0 |
| 2026-05-08 | $16.84 | 0 |
| 2026-05-07 | $16.84 | 0 |
| 2026-05-06 | $16.84 | 500 |
| 2026-05-05 | $13.55 | 0 |
About BrainsWay Ltd.
BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious and late-life depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post-traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. The company was founded in 2003 and is headquartered in Jerusalem, Israel.
đ° Latest News
Undiscovered Gems in Middle East Stocks for May 2026
Simply Wall St. âĸ 2026-05-26T08:32:54Z
BrainsWay Ltd (BRSYF) Q1 2026 Earnings Call Highlights: Record Revenue Growth and Strategic ...
GuruFocus.com âĸ 2026-05-13T23:02:02ZBrainsway Q1 Earnings Call Highlights
MarketBeat âĸ 2026-05-13T14:07:48Z
Full Transcript: BrainsWay Q1 2026 Earnings Call
Benzinga âĸ 2026-05-13T13:46:26Z
Are Medical Stocks Lagging Brainsway (BWAY) This Year?
Zacks âĸ 2026-05-04T13:40:03Z
5 Stocks With Recent Price Strength to Gain From April Rally
Zacks âĸ 2026-05-04T12:43:00ZRecent Price Trend in Brainsway (BWAY) is Your Friend, Here's Why
Zacks âĸ 2026-04-29T12:55:02Z
Zacks Industry Outlook Highlights Phibro Animal Health, BioLife Solutions, Omeros and Brainsway
Zacks âĸ 2026-04-28T14:42:00Z
Exploring Three Undiscovered Gems in the Middle East Market
Simply Wall St. âĸ 2026-04-16T03:32:58Z
Are Medical Stocks Lagging Alcon (ALC) This Year?
Zacks âĸ 2026-04-14T13:40:02Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $9,063,000 | $7,249,000 | $6,050,000 | $5,384,000 |
| Cost Of Revenue | $10,435,000 | $8,308,000 | $7,129,000 | $6,599,000 |
| Total Revenue | $41,016,000 | $31,785,000 | $27,177,000 | $29,657,000 |
| Operating Revenue | $41,016,000 | $31,785,000 | $27,177,000 | $29,657,000 |
| Expenses | ||||
| Interest Expense | $127,000 | $48,000 | $46,000 | $60,000 |
| Total Expenses | $39,625,000 | $36,744,000 | $39,860,000 | $34,656,000 |
| Other Income Expense | $947,000 | $-284,000 | $-244,000 | $-333,000 |
| Net Non Operating Interest Income Expense | $1,121,000 | $1,297,000 | $-107,000 | $-1,087,000 |
| Total Other Finance Cost | $1,229,000 | $826,000 | $1,170,000 | $1,252,000 |
| Interest Expense Non Operating | $127,000 | $48,000 | $46,000 | $60,000 |
| Operating Expense | $29,190,000 | $28,436,000 | $32,731,000 | $28,057,000 |
| Selling And Marketing Expense | $6,790,000 | $5,920,000 | $7,302,000 | $6,231,000 |
| General And Administrative Expense | $14,241,000 | $15,718,000 | $17,015,000 | $14,639,000 |
| Rent Expense Supplemental | - | - | $2,202,000 | $3,090,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $2,921,000 | $-4,197,000 | $-13,349,000 | $-6,462,000 |
| Net Interest Income | $1,121,000 | $1,297,000 | $-107,000 | $-1,087,000 |
| Interest Income | $2,477,000 | $2,171,000 | $1,109,000 | $225,000 |
| Normalized Income | $2,121,293 | $-3,978,320 | $-13,161,120 | $-6,205,590 |
| Net Income From Continuing And Discontinued Operation | $2,921,000 | $-4,197,000 | $-13,349,000 | $-6,462,000 |
| Total Operating Income As Reported | $1,391,000 | $-4,959,000 | $-12,683,000 | $4,999,000 |
| Net Income Common Stockholders | $2,921,000 | $-4,197,000 | $-13,349,000 | $-6,462,000 |
| Net Income | $2,921,000 | $-4,197,000 | $-13,349,000 | $-6,462,000 |
| Net Income Including Noncontrolling Interests | $2,921,000 | $-4,197,000 | $-13,349,000 | $-6,462,000 |
| Net Income Continuous Operations | $2,921,000 | $-4,197,000 | $-13,349,000 | $-6,462,000 |
| Pretax Income | $3,459,000 | $-3,946,000 | $-13,034,000 | $-6,419,000 |
| Interest Income Non Operating | $2,477,000 | $2,171,000 | $1,109,000 | $225,000 |
| Operating Income | $1,391,000 | $-4,959,000 | $-12,683,000 | $-4,999,000 |
| Depreciation Amortization Depletion Income Statement | $399,000 | $278,000 | $455,000 | $471,000 |
| Depreciation And Amortization In Income Statement | $399,000 | $278,000 | $455,000 | $471,000 |
| Depreciation Income Statement | $399,000 | $278,000 | $455,000 | $471,000 |
| Gross Profit | $30,581,000 | $23,477,000 | $20,048,000 | $23,058,000 |
| Per Share | ||||
| Diluted EPS | $0.09 | $-0.13 | $-0.40 | $-0.21 |
| Basic EPS | $0.09 | $-0.13 | $-0.40 | $-0.21 |
| Other | ||||
| Tax Effect Of Unusual Items | $147,293 | $-65,320 | $-56,120 | $-76,590 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $4,410,000 | $-2,277,000 | $-11,210,000 | $-4,340,000 |
| Total Unusual Items | $947,000 | $-284,000 | $-244,000 | $-333,000 |
| Total Unusual Items Excluding Goodwill | $947,000 | $-284,000 | $-244,000 | $-333,000 |
| Reconciled Depreciation | $1,771,000 | $1,337,000 | $1,534,000 | $1,686,000 |
| EBITDA (Bullshit earnings) | $5,357,000 | $-2,561,000 | $-11,454,000 | $-4,673,000 |
| EBIT | $3,586,000 | $-3,898,000 | $-12,988,000 | $-6,359,000 |
| Diluted Average Shares | $32,455,556 | $32,284,615 | $33,372,500 | $30,771,429 |
| Basic Average Shares | $32,455,556 | $32,284,615 | $33,372,500 | $30,771,429 |
| Diluted NI Availto Com Stockholders | $2,921,000 | $-4,197,000 | $-13,349,000 | $-6,462,000 |
| Tax Provision | $538,000 | $251,000 | $315,000 | $43,000 |
| Gain On Sale Of Security | $947,000 | $-284,000 | $-244,000 | $-333,000 |
| Provision For Doubtful Accounts | $570,000 | $-145,000 | $281,000 | $323,000 |
| Research And Development | $7,190,000 | $6,665,000 | $7,678,000 | $6,393,000 |
| Selling General And Administration | $21,031,000 | $21,638,000 | $24,317,000 | $20,870,000 |
| Other Gand A | $2,050,000 | $2,654,000 | $3,321,000 | $2,041,000 |
| Salaries And Wages | $12,191,000 | $13,064,000 | $13,694,000 | $12,598,000 |
Fetched: 2026-02-02
Balance Sheet (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $62,313,000 | $41,581,000 | $45,397,000 | $57,325,000 |
| Total Assets | $94,316,000 | $62,972,000 | $64,477,000 | $75,732,000 |
| Total Non Current Assets | $14,646,000 | $7,507,000 | $6,388,000 | $10,285,000 |
| Non Current Prepaid Assets | $1,635,000 | $889,000 | $766,000 | - |
| Non Current Deferred Assets | $1,063,000 | $828,000 | $276,000 | - |
| Non Current Deferred Taxes Assets | $1,063,000 | $828,000 | $276,000 | - |
| Current Assets | $79,670,000 | $55,465,000 | $58,089,000 | $65,447,000 |
| Other Current Assets | $1,032,000 | $1,712,000 | $1,556,000 | $1,566,000 |
| Restricted Cash | $271,000 | $271,000 | $271,000 | - |
| Inventory | $4,426,000 | $3,717,000 | $3,837,000 | $200,000 |
| Receivables | $4,596,000 | $3,780,000 | $4,844,000 | $6,332,000 |
| Accounts Receivable | $4,596,000 | $3,780,000 | $4,844,000 | $6,332,000 |
| Allowance For Doubtful Accounts Receivable | $-1,162,000 | $-904,000 | $-1,101,000 | $-1,256,000 |
| Gross Accounts Receivable | $5,758,000 | $4,684,000 | $5,945,000 | $7,588,000 |
| Cash Cash Equivalents And Short Term Investments | $69,345,000 | $45,985,000 | $47,581,000 | $57,349,000 |
| Cash And Cash Equivalents | $69,345,000 | $10,520,000 | $47,581,000 | $16,921,000 |
| Cash Equivalents | $55,277,000 | $0 | $40,274,000 | $1,450,000 |
| Cash Financial | $14,068,000 | $10,520,000 | $7,307,000 | $15,471,000 |
| Other Non Current Assets | - | - | $1,042,000 | $954,000 |
| Other Receivables | - | - | $606,000 | $388,000 |
| Prepaid Assets | - | - | - | $1,178,000 |
| Debt | ||||
| Total Debt | $5,624,000 | $471,000 | $488,000 | $754,000 |
| Long Term Debt And Capital Lease Obligation | $4,800,000 | $239,000 | $254,000 | $254,000 |
| Current Debt And Capital Lease Obligation | $824,000 | $232,000 | $234,000 | $500,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $32,003,000 | $21,391,000 | $19,080,000 | $18,407,000 |
| Total Non Current Liabilities Net Minority Interest | $16,657,000 | $11,630,000 | $10,939,000 | $9,340,000 |
| Derivative Product Liabilities | $2,429,000 | $0 | - | - |
| Non Current Deferred Liabilities | $9,428,000 | $11,391,000 | $4,669,000 | $3,157,000 |
| Current Liabilities | $15,346,000 | $9,761,000 | $8,141,000 | $9,067,000 |
| Current Deferred Liabilities | $5,727,000 | $3,512,000 | $1,477,000 | $2,195,000 |
| Payables And Accrued Expenses | $6,071,000 | $3,952,000 | $3,505,000 | $4,255,000 |
| Payables | $3,495,000 | $1,472,000 | $1,196,000 | $1,356,000 |
| Other Payable | $250,000 | $153,000 | - | - |
| Total Tax Payable | $268,000 | $504,000 | $0 | $18,000 |
| Income Tax Payable | $268,000 | $504,000 | - | - |
| Accounts Payable | $2,868,000 | $758,000 | $1,116,000 | $1,102,000 |
| Other Non Current Liabilities | - | $6,077,000 | $6,016,000 | $5,929,000 |
| Other Current Liabilities | - | $1,008,000 | $1,057,000 | $978,000 |
| Equity | ||||
| Common Stock Equity | $62,313,000 | $41,581,000 | $45,397,000 | $57,325,000 |
| Total Equity Gross Minority Interest | $62,313,000 | $41,581,000 | $45,397,000 | $57,325,000 |
| Stockholders Equity | $62,313,000 | $41,581,000 | $45,397,000 | $57,325,000 |
| Other Equity Interest | $4,872,000 | $4,360,000 | $6,180,000 | $5,340,000 |
| Gains Losses Not Affecting Retained Earnings | $-2,188,000 | $-2,188,000 | $-2,188,000 | $-2,188,000 |
| Retained Earnings | $-98,381,000 | $-101,302,000 | $-97,105,000 | $-83,756,000 |
| Other Equity Adjustments | - | - | - | $5,340,000 |
| Other | ||||
| Ordinary Shares Number | $37,626,427 | $33,242,189 | $33,053,323 | $32,911,134 |
| Share Issued | $37,626,427 | $33,242,189 | $33,053,323 | $32,911,134 |
| Tangible Book Value | $62,313,000 | $41,581,000 | $45,397,000 | $57,325,000 |
| Invested Capital | $62,313,000 | $41,581,000 | $45,397,000 | $57,325,000 |
| Working Capital | $64,324,000 | $45,704,000 | $49,948,000 | $56,380,000 |
| Capital Lease Obligations | $5,624,000 | $471,000 | $488,000 | $754,000 |
| Total Capitalization | $62,313,000 | $41,581,000 | $45,397,000 | $57,325,000 |
| Foreign Currency Translation Adjustments | $-2,188,000 | $-2,188,000 | $-2,188,000 | $-2,188,000 |
| Additional Paid In Capital | $157,597,000 | $140,344,000 | $138,146,000 | $137,566,000 |
| Capital Stock | $413,000 | $367,000 | $364,000 | $363,000 |
| Common Stock | $413,000 | $367,000 | $364,000 | $363,000 |
| Non Current Deferred Revenue | $9,428,000 | $11,391,000 | $4,669,000 | $3,157,000 |
| Long Term Capital Lease Obligation | $4,800,000 | $239,000 | $254,000 | $254,000 |
| Current Deferred Revenue | $5,727,000 | $3,512,000 | $1,477,000 | $2,195,000 |
| Current Capital Lease Obligation | $824,000 | $232,000 | $234,000 | $500,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $2,724,000 | $2,065,000 | $1,868,000 | $1,139,000 |
| Current Accrued Expenses | $2,576,000 | $2,480,000 | $2,309,000 | $2,899,000 |
| Dueto Related Parties Current | $109,000 | $57,000 | $80,000 | $236,000 |
| Net PPE | $11,948,000 | $5,790,000 | $5,346,000 | $9,331,000 |
| Accumulated Depreciation | $-6,135,000 | $-6,295,000 | $-5,497,000 | $-5,604,000 |
| Gross PPE | $18,083,000 | $12,085,000 | $10,843,000 | $14,935,000 |
| Leases | $394,000 | $102,000 | $81,000 | $69,000 |
| Other Properties | $9,888,000 | $9,767,000 | $9,261,000 | $13,561,000 |
| Machinery Furniture Equipment | $2,512,000 | $1,920,000 | $1,501,000 | $1,305,000 |
| Buildings And Improvements | $5,289,000 | $296,000 | - | - |
| Properties | $0 | $0 | $0 | $0 |
| Inventories Adjustments Allowances | $-1,150,000 | $-1,118,000 | $-1,606,000 | - |
| Finished Goods | $2,573,000 | $1,833,000 | $1,227,000 | - |
| Work In Process | $208,000 | $1,211,000 | $1,651,000 | - |
| Raw Materials | $2,795,000 | $1,791,000 | $2,565,000 | $200,000 |
| Other Short Term Investments | $0 | $35,465,000 | $0 | $40,428,000 |
| Other Inventories | - | - | $3,837,000 | - |
Fetched: 2026-02-02
Cash Flow Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $6,504,000 | $-1,103,000 | $-9,760,000 | $-1,354,000 |
| Operating Activities | ||||
| Operating Cash Flow | $10,298,000 | $1,284,000 | $-9,760,000 | $884,000 |
| Cash Flow From Continuing Operating Activities | $10,298,000 | $1,284,000 | $-9,760,000 | $884,000 |
| Investing Activities | ||||
| Capital Expenditure | $-3,794,000 | $-2,387,000 | - | $-2,238,000 |
| Investing Cash Flow | $30,311,000 | $-37,409,000 | $42,169,000 | $-42,216,000 |
| Cash Flow From Continuing Investing Activities | $30,311,000 | $-37,409,000 | $42,169,000 | $-42,216,000 |
| Net Other Investing Changes | $76,000 | - | - | - |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $0 | $0 | $-52,000 | - |
| Issuance Of Capital Stock | $16,353,000 | $0 | $0 | $42,260,000 |
| Financing Cash Flow | $18,263,000 | $-1,026,000 | $-1,547,000 | $41,516,000 |
| Cash Flow From Continuing Financing Activities | $18,263,000 | $-1,026,000 | $-1,547,000 | $41,516,000 |
| Net Other Financing Charges | $-1,108,000 | $-755,000 | $-962,000 | $-269,000 |
| Net Common Stock Issuance | $16,353,000 | $0 | $-52,000 | $42,260,000 |
| Common Stock Issuance | $16,353,000 | $0 | $0 | $42,260,000 |
| Other | ||||
| Repayment Of Debt | $-424,000 | $-271,000 | $-533,000 | $-475,000 |
| End Cash Position | $69,345,000 | $10,520,000 | $47,581,000 | $16,921,000 |
| Beginning Cash Position | $10,520,000 | $47,581,000 | $16,921,000 | $16,961,000 |
| Effect Of Exchange Rate Changes | $-47,000 | $90,000 | $-202,000 | $-224,000 |
| Changes In Cash | $58,872,000 | $-37,151,000 | $30,862,000 | $184,000 |
| Proceeds From Stock Option Exercised | $3,442,000 | $0 | $0 | - |
| Common Stock Payments | $0 | $0 | $-52,000 | - |
| Net Issuance Payments Of Debt | $-424,000 | $-271,000 | $-533,000 | $-475,000 |
| Net Long Term Debt Issuance | $-424,000 | $-271,000 | $-533,000 | $-475,000 |
| Long Term Debt Payments | $-424,000 | $-271,000 | $-533,000 | $-475,000 |
| Net Investment Purchase And Sale | $34,029,000 | $-35,022,000 | $40,233,000 | $-39,978,000 |
| Sale Of Investment | $35,000,000 | $0 | $40,254,000 | $22,000 |
| Purchase Of Investment | $-971,000 | $-35,022,000 | $-21,000 | $-40,000,000 |
| Net PPE Purchase And Sale | $-3,794,000 | $-2,387,000 | $1,936,000 | $-2,238,000 |
| Taxes Refund Paid | $-1,009,000 | $-11,000 | $-443,000 | $-14,000 |
| Interest Received Cfo | $2,922,000 | $1,707,000 | $1,042,000 | $17,000 |
| Interest Paid Cfo | $-124,000 | $-253,000 | $-46,000 | $-62,000 |
| Change In Working Capital | $2,387,000 | $1,635,000 | $-1,454,000 | $1,068,000 |
| Change In Other Working Capital | $277,000 | $1,629,000 | $790,000 | $2,039,000 |
| Change In Other Current Assets | $1,649,000 | $-312,000 | $-403,000 | $-1,226,000 |
| Change In Payables And Accrued Expense | $2,248,000 | $-265,000 | $298,000 | $1,104,000 |
| Change In Payable | $2,248,000 | $-265,000 | $298,000 | $1,104,000 |
| Change In Account Payable | $2,119,000 | $-327,000 | $0 | $289,000 |
| Change In Inventory | $-920,000 | $-506,000 | $-3,595,000 | $0 |
| Change In Receivables | $-867,000 | $1,089,000 | $1,456,000 | $-849,000 |
| Changes In Account Receivables | $-867,000 | $1,089,000 | $1,456,000 | $-849,000 |
| Other Non Cash Items | $-2,068,000 | $-1,013,000 | $351,000 | $1,420,000 |
| Stock Based Compensation | $1,441,000 | $381,000 | $1,474,000 | $1,893,000 |
| Asset Impairment Charge | $1,519,000 | $1,447,000 | $816,000 | $1,295,000 |
| Deferred Tax | $538,000 | $251,000 | $315,000 | $43,000 |
| Deferred Income Tax | $538,000 | $251,000 | $315,000 | $43,000 |
| Depreciation Amortization Depletion | $1,771,000 | $1,337,000 | $1,534,000 | $1,686,000 |
| Depreciation And Amortization | $1,771,000 | $1,337,000 | $1,534,000 | $1,686,000 |
| Depreciation | $1,771,000 | $1,337,000 | $1,534,000 | $1,686,000 |
| Net Income From Continuing Operations | $2,921,000 | $-4,197,000 | $-13,349,000 | $-6,462,000 |
| Purchase Of PPE | - | - | - | $-2,238,000 |
Fetched: 2026-02-02